Pharmaceutical products supplier UK and Europe: Reliable commercial drug sourcing and supply for clinical research, with a truly global approach. ClientPharma is perfectly equipped to ensure fast, accurate and reliable pharmaceutical supply. With unparalleled service and unmatched access, ClientPharma sources and supplies commercial drug product for global clinical trials. From provision of clinical research samples, to bulk supplies for your pivotal trials, we have the network and know-how to provide strategic sourcing solutions at every stage of clinical research. See even more info on pharmaceutical risk mitigation and competitiveness.

We profoundly understand and recognize the numerous risks associated with global drug procurement. We also appreciate the many complexities associated with worldwide storage and distribution of clinical trial supplies. Our team knows the importance of an efficient, robust supply chain — audited & approved — that promotes excellence, security and accountability. We provide batch traceability, supporting documentation (i.e. Certificates of Analysis (CofAs), Batch Release Certificates (BRCs), GMP Statements, stability data, Fit-for-Use (FFU) Statements, Certificates of Conformance (CofCs), Certificates of Origin (CofOs), etc.) and temperature monitoring data – delivering product pedigree and authenticity.

Unbeatable global access to commercial drug products – Unlike many comparator drug sourcing companies, our ethos is to challenge the norms and adapt to your specific needs. We understand the complexities and challenges of multi-faceted projects with time and temperature specifics. Using a combined understanding of your clinical requisites and our extensive knowledge of the commercial market landscape, we work to design a supply strategy unique to your needs. Ask our team for a customized product supply assessment.

ClientPharma is proud to be the new sponsor of the Stretton Starlings netball team, continuing our goal to support equality in sports. As a result, we wish to showcase the team’s smart new match uniforms for the upcoming season, which sets a new precedent as an innovative way forward with the team wearing t-shirts rather than the ‘status quo’ netball dresses. After forming the team six months ago, the Starlings have just completed their first season collectively in a competitive netball league for the first time, emphasizing that age is no barrier with a range from 14 to 47 years old. The team has high expectations for the upcoming season and wishes to inspire, grow, develop, and celebrate local talent in welcoming ladies of all ages and abilities to come and join the team! Stretton Starlings are eager, driven and determined to commence the second season of the Leagues4you Burton-Upon-Trent Netball League, starting from the 9th of January 2023. Discover extra details on https://www.clientpharma.com/.

Meeting the needs of global clinical supply trials requires diversity in supply strategies to address the unique complexities of each country’s healthcare and medication distribution systems. The “one-size fits all” approach is not a single supply strategy; instead, it leverages the expertise of a supply vendor partnership that addresses the need for a multi-faceted supply chain strategy. Jeff Wiltrout, Ph.D., Senior Vice President of Business Development at TrialCard, stated, “The responsibilities of clinical trial supply and operations personnel are vast and intricate. They need partners that make complex tasks simple and efficient. The partnership between market leaders like TrialCard and ClientPharma simplifies our clients’ global commercial drug sourcing responsibilities by providing a variety of streamlined, agile and efficient processes.”

Forecasts by their very definition involve a degree of uncertainty. When a company fails to meet demand it can have major implications on the drug and the pharmaceutical company. The company may experience loss in sales, a bad reputation for unreliability with customers and overworked employees. It has been reported that where the drug itself is concerned, if the launch of a medicine is delayed due to a failure in estimation, it costs on average $15 million per drug, per day. Further research has also shown that a blockbuster drug will lose $1 billion in revenue annually until capacity is developed to meet demand. Overestimations in demand generally happen when the market is at its most volatile, or, if the reach of a new drug has been over estimated. These inaccuracies can cost companies. If a product’s demand is overestimated, companies have to find ways to correct their misjudgement by cutting the price of medicines which reduces margins and by making employees redundant to pay for the excess of stock. In some cases companies also have to destroy stock that has not been sold.